Outcomes and Resource Utilization Associated with Use of Routine Pre-Discharge White Blood Cell Count for Clinical Decision-Making in Children with Complicated Appendicitis: A Multicenter Hospital-Level Analysis.


Journal

Journal of pediatric surgery
ISSN: 1531-5037
Titre abrégé: J Pediatr Surg
Pays: United States
ID NLM: 0052631

Informations de publication

Date de publication:
Jun 2023
Historique:
received: 27 01 2023
accepted: 10 02 2023
medline: 22 5 2023
pubmed: 9 4 2023
entrez: 8 4 2023
Statut: ppublish

Résumé

The objective was to explore the hospital-level relationship between routine pre-discharge WBC utilization (RPD-WBC) and outcomes in children with complicated appendicitis. Multicenter analysis of NSQIP-Pediatric data from 14 consortium hospitals augmented with RPD-WBC data. WBC were considered routine if obtained within one day of discharge in children who did not develop an organ space infection (OSI) or fever during the index admission. Hospital-level observed-to-expected ratios (O/E) for 30-day outcomes (antibiotic days, imaging utilization, healthcare days, and OSI) were calculated after adjusting for appendicitis severity and patient characteristics. Spearman correlation was used to explore the relationship between hospital-level RPD-WBC utilization and O/E's for each outcome. 1528 children were included. Significant variation was found across hospitals in RPD-WBC use (range: 0.7-100%; p < 0.01) and all outcomes (mean antibiotic days: 9.9 [O/E range: 0.56-1.44, p < 0.01]; imaging: 21.9% [O/E range: 0.40-2.75, p < 0.01]; mean healthcare visit days: 5.7 [O/E 0.74-1.27, p < 0.01]); OSI: 14.1% [O/E range: 0.43-3.64, p < 0.01]). No correlation was found between RPD-WBC use and antibiotic days (r = +0.14, p = 0.64), imaging (r = -0.07, p = 0.82), healthcare days (r = +0.35, p = 0.23) or OSI (r = -0.13, p = 0.65). Increased RPD-WBC utilization in pediatric complicated appendicitis did not correlate with improved outcomes or resource utilization at the hospital level. III. Clinical Research.

Sections du résumé

BACKGROUND BACKGROUND
The objective was to explore the hospital-level relationship between routine pre-discharge WBC utilization (RPD-WBC) and outcomes in children with complicated appendicitis.
METHODS METHODS
Multicenter analysis of NSQIP-Pediatric data from 14 consortium hospitals augmented with RPD-WBC data. WBC were considered routine if obtained within one day of discharge in children who did not develop an organ space infection (OSI) or fever during the index admission. Hospital-level observed-to-expected ratios (O/E) for 30-day outcomes (antibiotic days, imaging utilization, healthcare days, and OSI) were calculated after adjusting for appendicitis severity and patient characteristics. Spearman correlation was used to explore the relationship between hospital-level RPD-WBC utilization and O/E's for each outcome.
RESULTS RESULTS
1528 children were included. Significant variation was found across hospitals in RPD-WBC use (range: 0.7-100%; p < 0.01) and all outcomes (mean antibiotic days: 9.9 [O/E range: 0.56-1.44, p < 0.01]; imaging: 21.9% [O/E range: 0.40-2.75, p < 0.01]; mean healthcare visit days: 5.7 [O/E 0.74-1.27, p < 0.01]); OSI: 14.1% [O/E range: 0.43-3.64, p < 0.01]). No correlation was found between RPD-WBC use and antibiotic days (r = +0.14, p = 0.64), imaging (r = -0.07, p = 0.82), healthcare days (r = +0.35, p = 0.23) or OSI (r = -0.13, p = 0.65).
CONCLUSIONS CONCLUSIONS
Increased RPD-WBC utilization in pediatric complicated appendicitis did not correlate with improved outcomes or resource utilization at the hospital level.
LEVEL OF EVIDENCE METHODS
III.
TYPE OF STUDY METHODS
Clinical Research.

Identifiants

pubmed: 37030979
pii: S0022-3468(23)00160-4
doi: 10.1016/j.jpedsurg.2023.02.039
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Multicenter Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1178-1184

Informations de copyright

Copyright © 2023 Elsevier Inc. All rights reserved.

Auteurs

Shannon L Cramm (SL)

Department of Surgery, Boston Children's Hospital, Boston, MA, USA.

Dionne A Graham (DA)

Program for Patient Safety and Quality, Boston Children's Hospital, Boston, MA, USA.

Martin L Blakely (ML)

Department of Surgery, Vanderbilt Children's Hospital, Vanderbilt School of Medicine, Nashville, TN, USA.

Nicole M Chandler (NM)

Division of Pediatric Surgery, Johns Hopkin's All Children's Hospital, St. Petersburg, FL, USA.

Robert A Cowles (RA)

Department of Pediatric Surgery, Yale New Haven Children's Hospital, Yale School of Medicine, New Haven, CT, USA.

Shaun M Kunisaki (SM)

Division of General Pediatric Surgery, Johns Hopkins Children's Center, Johns Hopkins School of Medicine, Baltimore, MD, USA.

Robert T Russell (RT)

Department of Surgery, Division of Pediatric Surgery, University of Alabama at Birmingham, Children's of Alabama.

Myron Allukian (M)

Division of Pediatric, General, Thoracic, and Fetal Surgery, Children's Hospital of Philadelphia, Philadelphia, PA, USA.

Jennifer R DeFazio (JR)

Division of Pediatric Surgery, New York Presbyterian Morgan Stanley Children's Hospital, Columbia University Vagelos Colleges of Physicians and Surgeons, New York, NY, USA.

Cornelia L Griggs (CL)

Department of Surgery, Division of Pediatric Surgery, Massachusetts General Hospital, Boston, MA, USA.

Matthew T Santore (MT)

Department of Surgery, Division of Pediatric Surgery, Children's Healthcare of Atlanta, Emory University, Atlanta, GA, USA.

Stefan Scholz (S)

Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.

Danielle I Aronowitz (DI)

Division of Pediatric, General, Thoracic, and Fetal Surgery, Children's Hospital of Philadelphia, Philadelphia, PA, USA.

Brendan T Campbell (BT)

Department of Surgery, Connecticut Children's Hospital, Hartford, CT, USA.

Devon T Collins (DT)

Department of Surgery, Children's National Hospital, Washington, D.C, USA.

Sarah J Commander (SJ)

Department of Surgery, Duke Children's Hospital and Health Center, Durham, NC, USA.

Abigail Engwall-Gill (A)

Division of General Pediatric Surgery, Johns Hopkins Children's Center, Baltimore, MD, USA.

Joseph R Esparaz (JR)

Department of Surgery, Division of Pediatric Surgery, University of Alabama at Birmingham, Children's of Alabama, Birmingham, AL, USA.

Christina Feng (C)

Department of Surgery, Duke Children's Hospital and Health Center, Durham, NC, USA.

Claire Gerall (C)

Department of Surgery, UT Health San Antonio, San Antonio, TX, USA.

David N Hanna (DN)

Department of Surgery, Vanderbilt Children's Hospital, Nashville, TN, USA.

Olivia A Keane (OA)

Department of Surgery, Division of Pediatric Surgery, Children's Healthcare of Atlanta, Emory University, Atlanta, GA, USA.

Abdulraouf Lamoshi (A)

Division of Pediatric Surgery, Cohen Children's Medical Center, New Hyde Park, NY, USA.

Aaron M Lipskar (AM)

Division of Pediatric Surgery, Cohen Children's Medical Center, Zucker School of Medicine at Hofstra/Northwell, New Hyde Park, NY, USA.

Claudia P Orlas Bolanos (CP)

Department of Surgery, Division of Pediatric Surgery, Massachusetts General Hospital, Boston, MA, USA.

Elizabeth Pace (E)

Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.

Maia D Regan (MD)

Department of Surgery, Children's National Hospital, Washington, D.C, USA.

Elisabeth T Tracy (ET)

Department of Surgery, Duke Children's Hospital and Health Center, Duke University School of Medicine, Durham, NC, USA.

Sacha Williams (S)

Division of Pediatric Surgery, Johns Hopkins All Children's Hospital, St. Petersburg, FL, USA.

Lucy Zhang (L)

Department of Pediatric Surgery, Yale New Haven Children's Hospital, New Haven, CT, USA.

Shawn J Rangel (SJ)

Department of Surgery, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA. Electronic address: shawn.rangel@childrens.harvard.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH